Singular Genomics Systems Inc P/B ratio is 0.2981. Fiscal Q4 2022 ended 12/31/22. The PX Instrument combines single cell and spatial analysis, genomics, and proteomics in one integrated instrument providing a versatile multiomics solution. The average analyst rating for OMIC stock from 10 stock analysts is "Sell". Singular Genomics Systems Stock Down 7.8 %. Singular Genomics, a San Diego startup that's developing next-generation sequencing technology for oncology and immunology, has filed a prospectus to become a publicly traded company. 22.60% of the stock of Singular Genomics Systems is held by insiders. Lorsque vous utilisez nos sites et applications, nous utilisons des, authentifier les utilisateurs, appliquer des mesures de scurit, empcher les spams et les abus; et. Singular Genomics Systems, Inc. Market Cap $92M Today's Change (3.91%) $0.05 Current Price $1.33 Price as of March 16, 2023, 4:00 p.m. Commodities. About Singular Genomics Systems, Inc. 10931 NORTH TORREY PINES ROAD SUITE NO.100, LA JOLLA, California, 92037, United States +1 858 333-7830 https://www.singulargenomics.com. Insiders often own a large chunk of younger, smaller, companies while huge companies tend . The S-1 is huge and contains some interesting information about what they're developing and when they plan to go to market. What is Singular Genomics Systems' stock price today? One share of OMIC stock can currently be purchased for approximately $1.08. The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associated menu of consumable kits. A second integrated solution in development comprises an instrument and an associated menu of consumable kits, which Singular Genomics refers to collectively as the PX Integrated Solution. Accordingly, you should not rely on forward-looking statements as predictions of future events or our future performance. Represents the company's profit divided by the outstanding shares of its common stock. portalId: 20463371, Funding, Valuation & Revenue. 3010 Science Park Rd San Diego, CA 92121 . Support +1 (442) 742-2737 support@singulargenomics.com. The analyst firm set a price target for 3.00 expecting OMIC to rise. Type a symbol or company name. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Singular Genomics Systems Inc's EBITDA is 0.47. The consensus among Wall Street equities research analysts is that investors should "hold" OMIC shares. What is the 52-week high for Singular Genomics Systems Inc? window.hsFormsOnReady = window.hsFormsOnReady || []; The stock has a 50-day simple moving average of $1. Nous, Yahoo, faisons partie de la famille de marques Yahoo. The G4 Sequencing Platform is designed to target the NGS market. Reported on 3/3/23. 10 stocks we like better than Singular Genomics Systems, Inc. May-26-21 11:56PM. See disclosure here. A lower score indicates better sustainability, Exposure refers to the extent to which a company is exposed to different material ESG issues, Management is related to actions taken to manage ESG issues. Cash, cash equivalents and short-term investments, excluding restricted cash, as of December 31, 2022 totaled $244.6million. A high percentage of insider ownership can be a sign of company health. Overview; . You can use the bid-ask spread to determine whether to place a market orderorlimit orderwhen trading, helping you to optimize your price and have a successful order execution. Is Ollies Bargain Outlets A Value Or A Trap? The numbers next to the bid/ask are the size. Singular Genomics is pushing sequencing further to bring fast, powerful and flexible tools for research and medicine. Singular Genomics Systems' stock was trading at $2.01 at the beginning of the year. })}); 2022 Singular Genomics Systems, Inc. All rights reserved. All rights reserved. ET by Tomi Kilgore. Find the latest Singular Genomics Systems, Inc. (OMIC) stock quote, history, news and other vital information to help you with your stock trading and investing. Here Are 5 Other Price Target Changes For Wednesday. Get short term trading ideas from the MarketBeat Idea Engine. Raising the bar with industry-leading run times across applications. Singular Genomics Systems, Inc. (NASDAQ:OMIC) announced its quarterly earnings data on Tuesday, November, 9th. Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology for researchers and clinicians to advance science and . 3 equities research analysts have issued 12 month target prices for Singular Genomics Systems' stock. Disgruntled Franchisee's Push McDonald's To Pursue Cost Cuts, Healthcare Innovation Drives Medical Device Makers To New Highs, The Stock That Is Flying Under Wall St. Radar, Singular Genomics Systems, Inc. (NASDAQ:OMIC) Q4 2022 Earnings Call Transcript, Q4 2022 Singular Genomics Systems Inc Earnings Call, Singular Genomics Systems GAAP EPS of -$0.29 beats by $0.15, revenue of $0.77M beats by $0.04M, Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial Results, Singular Genomics to Present at Cowen's 43rd Annual Health Care Conference, Singular Genomics to Present at Cowens 43rd Annual Health Care Conference, Singular Genomics Launches Max Read Kits for Single Cell Sequencing on the G4 at AGBT, Singular Genomics Showcases New G4 Sequencing Platform Data with 11 Industry-Leading Genomics Partners at AGBT. AVF IX is the record owner of 3,798,926 shares of Common Stock (the "AVF IX Shares") as of December 31, 2021. On average, they predict the company's stock price to reach $3.50 in the next year. Defense. With these products, Singular Genomics mission is to empower researchers and clinicians to advance science and medicine. 326 E 8th St #105, Sioux Falls, SD 57103 Singular Genomics's latest funding round was a IPO for $178.5M on May 27, 2021. Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial Results. Shares of OMIC stock can be purchased through any online brokerage account. Industry News. What is the 50-day moving average of Singular Genomics Systems Inc? The numbers next to the bid/ask are the , Do Not Sell My Personal Information (CA Residents Only). Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial Results, Change in fair value of convertible promissory notes, Change in fair value of warrant liability, Weighted-average shares used to compute basic and diluted net loss per share, Prepaid expenses and other current assets, Series A common stock equivalent convertible preferred stock, $0.0001 par value; 7,000 shares authorized, 2,500 and no shares issued and outstanding at December 31, 2022 and December 31, 2021, respectively, Common stock, $0.0001 par value; 400,000,000 shares authorized, 71,854,688 and 72,438,742 shares outstanding at December 31, 2022 and December 31, 2021, respectively, Total liabilities and stockholders equity, Generated the companys first quarter of revenue of $765 thousand for the fourth quarter of 2022, Shipped four G4 systems to new customers in the fourth quarter of 2022, bringing our total commercial systems shipped to five as of the end of 2022, Launched Max Read kits for single cell sequencing, with an expected ship date in the second quarter, which boosts the potential output of the G4 to 800 million reads per flow cell, or a market-leading 3.2 billion reads per run on a benchtop system, Joined the 10x Genomics Compatible Partner Program, demonstrating compatibility of the G4 sequencing platform with 10x Genomics single cell applications, Increased the quality specifications for the G4 to 80%90% Q30, Raised the throughput range of the F2 and F3 flow cells to up to 250 million and up to 450 million reads, respectively, Produced 14 new data sets, 11 with industry-leading genomics partners, showcasing high accuracy of the G4 across many diverse applications. Active, Closed, Last funding round type (e.g. Investors may trade in the Pre-Market (4:00-9:30 a.m. The product development pipeline comprises two initial integrated solutions, each designed to leverage Sequencing Engine and purpose built . Jan. 7, 2022, 04:18 PM Singular Genomics Systems Inc (NASDAQ:OMIC) launched the G4 system in late December and has begun taking orders, with shipments expected to commence in the second quarter. Legal Name Singular Genomics Systems, Inc. Stock Symbol NASDAQ:OMIC. SAN DIEGO, March 02, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researc. . Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. In 2023, we will remain focused on customer success across a growing installed base, commercial and operational execution, and advancing our innovation pipeline.. Data Link's cloud-based technology platform allows you to search, discover and access data and analytics for seamless integration via cloud APIs. Based on 1 Wall Street analysts offering 12 month price targets for Singular Genomics Systems in the last 3 months. Stock ticker symbol (e.g. What is the Price-to-Book ratio of Singular Genomics Systems Inc? Singular Genomics is a life science technology company that is leveraging novel, next generation sequencing (NGS) and multiomics technologies to build products that empower researchers and clinicians. PitchBooks non-financial metrics help you gauge a companys traction and growth using web presence and social reach. The estimated base pay is $141,278 per year. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. The year-over-year increase in operating expenses was driven primarily by scaling headcount and infrastructure to support our growth, including the G4 launch, product pipeline and R&D roadmap. Singular Genomics Systems (NASDAQ:OMIC) Stock Price Down 7.8%. In-depth profiles and analysis for 20,000 public companies. Operating expenses for the fourth quarter of 2022 totaled$22.5 million, compared to $19.7 million for the fourth quarter of 2021. It was a year in which we achieved important milestones, overcame challenges, and ultimately ended on a strong note with five G4 systems in market. Singular Genomics Systems, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2023 10-K Annual Report includes: Voting Procedures; . 2022 was a pivotal year for Singular Genomics. View our OMIC earnings forecast. View which stocks are hot on social media with MarketBeat's trending stocks report. Check out the data and content presented at the show. Register for your free account today atdata.nasdaq.com. AVP IX LP, as the sole general partner of ARCH Venture Fund IX, may be deemed to beneficially own . formId: "6d6c14f2-ba94-427d-bb5a-a595d4237b34", The PX Integrated Solution combines single cell analysis, spatial analysis, genomics and proteomics in one integrated instrument providing a versatile multiomics solution. August 19, 2022|markets.businessinsider.com, August 17, 2022|markets.businessinsider.com. These risks and uncertainties include and are not limited to the following: (i) we have incurred significant losses since inception, we expect to incur significant losses in the future and we may not be able to generate sufficient revenue to achieve and maintain profitability; (ii) we have very little history manufacturing and commercializing our products or technology; (iii) the life sciences technology market is highly competitive, and if we fail to compete effectively, our business and operating results will suffer; (iv) if we are sued for infringing, misappropriating or otherwise violating intellectual property rights of third parties, such litigation could be costly and time consuming and could prevent or delay us from developing or commercializing our products; (v) if our products fail to achieve early customer and scientific acceptance, we may not be able to achieve broader market acceptance for our products, and our revenues and prospects may be harmed; (vi) we expect to be highly dependent upon revenue generated from the sale of the G4 and planned PX, and any delay or failure by us to successfully manufacture and commercialize the G4 and planned PX could have a substantial adverse effect on our business and results of operations; and (vii) the COVID-19 pandemic, efforts to reduce its spread and recent macroeconomic challenges have adversely impacted, and may materially and adversely impact, our business, operations and product manufacturing and commercialization objectives. Market Cap (Capitalization) is a measure of the estimated value of the common equity securities of the company or their equivalent. Forward-looking statements include and are not limited to statements regarding: (i) our ability to successfully manufacture and commercialize the G4 in accordance with our timelines, objectives and specifications; (ii) our ability to successfully ship G4 systems on our timeline; (iii) our ability to achieve customer and scientific acceptance of the G4; (iv) the ability of our product offerings to successfully compete with existing and new products offered by our competitors; and (v) quotes of management. After all, the newsletter they have run for over a decade . 3, 2022 at 10:25 a.m. 3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Singular Genomics Systems in the last twelve months. Operating Status Active. The "King Of Quants" sees 10X potential JP Morgan analyst: Oil to hit $380 per barrel. SAN DIEGO, March 02, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today highlighted recent corporate achievements and reported financial results for the fourth quarter and full year ended . Singular Genomics is a biotech company focused on delivering genomic technologies for the advancement of science and medicine. Its calculated by dividing the current share price by the earnings per share (or EPS). The company's average rating score is 1.67, and is based on no buy ratings, 2 hold ratings, and 1 sell rating. This suggests a possible upside of 250.0% from the stock's current price. You might be interested in: Digihost Technology Shares Down 4.2%. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. Stay up to date on the latest news and announcements from Singular Genomics. How were Singular Genomics Systems' earnings last quarter? We are a life science technology company leveraging novel next generation sequencing (NGS) and multiomics technologies to build products that empower researchers and clinicians. Jobs and Labor. The company can be reached via phone at 858-333-7830. Public Fundamental Data provided by Morningstar, Inc. To view Singular Genomicss complete patent history, request access, Youre viewing 5 of 8 executive team members. Singular Genomic Systems S-1 Review. This suggests a possible upside of 224.1% from the stock's current price. Pour en savoir plus sur la faon dont nous utilisons vos donnes personnelles, veuillez consulter notre politique relative la vie prive et notre politique en matire de cookies. The company employs 221 workers across the globe. Data reflects weightings calculated at the beginning of each month. Receive OMIC Stock News and Ratings via Email. On September 30, 2021 (the Closing Date), Singular Genomics Systems, Inc. refinanced its existing loan with Silicon Valley Bank (the "Lender"). Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at investor.singulargenomics.com , in the Presentations & Events section. Singular Genomics Systems Inc 50-day moving average is $1.71. Net loss for 2022 was $90.9 million, or a loss of $1.28 per common share, compared to $98.8 million, or a loss of $2.10 per common share, in 2021. Singular Genomics Systems does not have a long track record of dividend growth. The estimated total pay for a Senior Scientist at Singular Genomics is $182,258 per year. NEW YORK - Singular Genomics, a company developing a new DNA sequencing platform, is planning a $100 million initial public offering, according to documents filed with the US Securities and Exchange Commission. Glassdoor has salaries, wages, tips, bonuses, and hourly pay based upon employee reports and estimates. If you had invested in Singular Genomics Systems stock at $25.72, your return over the last 1 years would have been -92.11%, for an annualized return of -92.11% (not including any dividends or dividend reinvestments). What is the PE ratio of Singular Genomics Systems Inc? Revenue was comprised predominantly of the revenue recognized on three instrument placements during the quarter. target: "#hbspt-form-1681761025000-5259139204", Singular Genomics Systems Inc. Additional Proxy Soliciting Materials - Form DEFA14A. Identify stocks that meet your criteria using seven unique stock screeners. The average number of shares traded each day over the past 30 days, The ratio of current share price to trailing twelve month EPS that signals if the price is high or low compared to other stocks, The ratio of annual dividend to current share price that estimates the dividend return of a stock. Except as required by law, we undertake no obligation to update publicly or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise. A high-level overview of Singular Genomics Systems, Inc. (OMIC) stock. An innovative benchtop sequencing platform with novel, high-performance chemistry and advanced engineering, optimized to deliver unmatched power, speed, and versatility. Singular Genomics Systems Inc (OMIC) stock is trading at $1.17 as of 1:47 PM on Monday, Apr 10, a loss of -$0.11, or -8.59% from the previous closing price of $1.28. hbspt.forms.create({ Singular Genomics' management team will host a conference call today, March 2, 2023, beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. I've previously written about Singular Genomics. Its calculated by dividing a companys market capitalization by its book value. View analysts price targets for OMIC or view top-rated stocks among Wall Street analysts. 56.33% of the stock of Singular Genomics Systems is held by institutions. How many employees does Singular Genomics Systems have? Since then, OMIC stock has decreased by 46.3% and is now trading at $1.08. Investors who anticipate trading during these times are strongly advised to use limit orders. American Consumer News, LLC dba MarketBeat 2010-2023. The total amount of income generated by the sale of goods or services related to the company's primary operations, Represents the total incurred expenses through normal operations, Companys earnings for a period net of operating costs, taxes, and interest. "Market Cap" is derived from the last sale price for the displayed class of listed securities and the total number of shares outstanding for both listed and unlisted securities (as applicable). Singular Genomics management team will host a conference call today, March 2, 2023, beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Get the latest Singular Genomics Systems, Inc. (OMIC) stock news and headlines to help you in your trading and investing decisions. Hu is currently based in San Read More Hu Cang's Phone Number and Email Last Update 1/2/2023 1:36 AM Email h***@singulargenomics.com Engage via Email Contact Number (***) ***-**** The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at investor.singulargenomics.com, in the Presentations & Events section. Please log in to your account or sign up in order to add this asset to your watchlist. The commercially available G4 Sequencing Platform is a powerful, highly versatile benchtop genomic sequencer designed to produce fast and accurate results. Upgrade to MarketBeat All Access to add more stocks to your watchlist. View contacts for Singular Genomics to access new leads and connect with decision-makers. Owning 46% shares,institutional owners seem interested in Singular Genomics Systems, Inc. (NASDAQ:OMIC), Eli Glezer Is The Founder of Singular Genomics Systems, Inc. (NASDAQ:OMIC) And They Just Picked Up 1.2% More Shares, A Singular Genomics Systems, Inc. (NASDAQ:OMIC) insider increased their holdings by 16% last year, Singular Genomics Systems, Inc. (OMIC) Q3 2022 Earnings Call Transcript, Singular Genomics to Report Third Quarter 2022 Financial Results on November 7, 2022, Singular Genomics Announces Updated Presentation Time at the Inaugural Gilmartin Group Emerging Growth Company Showcase, Apple To $220? We are advancing genomics, together. It now looks like their preparing for an IPO and have filed an S-1. Singular Genomics. The company reported ($0.25) earnings per share for the quarter, missing the consensus estimate of ($0.24) by $0.01. Singular Genomics stock price target cut to $15 from $25 at UBS. The company has partnerships with Agilent Technologies, Dovetail Genomics, Lexogen, New England Biolab, QIAGEN, Roche, Twist Bioscience, and Watchmaker Genomics to validate their library preparation kits on the G4, as well as the Broad Institute of MIT and Harvard to connect the G4 to Terra platform, a data platform. Their OMIC share price forecasts range from $3.00 to $4.50. In development, the PX system leverages Singulars proprietary sequencing technology, applying it as an in-situ readout to look at RNA and proteins in single cells and tissue. window.hsFormsOnReady.push(()=>{ Certain statements contained in this press release, other than historical information, constitute forward-looking statements within the meaning of the federal securities laws. Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial Results SAN DIEGO, March 02, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today highlighted recent corporate achievements and reported financial . Singular Genomics Systems, Inc. Si vous souhaitez personnaliser vos choix, cliquez sur Grer les paramtres de confidentialit. Singular Genomics Systems Inc is a life science technology company that is leveraging novel next generation sequencing and multiomics technologies to build products that empower researchers and clinicians. How do I buy shares of Singular Genomics Systems? Export data to Excel for your own analysis. Founders Drew Spaventa, Eli Glezer. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Revenue for the fourth quarter of 2022 was $765 thousand, marking the first revenue generating quarter. Mar. This data feed is available via Nasdaq Data Link APIs; to learn more about subscribing, visitNasdaq Data Link's products page. Singular Genomics is a life science technology company that is leveraging novel, next generation sequencing (NGS) and multiomics technologies to build products that empower researchers and clinicians. Intentionally designed to alleviate challenges faced by researchers in the lab today, the G4 Sequencing Platform features advanced engineering and novel chemistry to deliver faster results, with more operational flexibility. Research & Science Based on 39 salaries Scientist II 5 salaries Scientist 5 salaries View More Engineering Based on 11 salaries QC Associate II 2 salaries Sr Engineer To explore Singular Genomicss full profile, request access. amount that a seller is currently willing to sell. Singular Genomics Systems (OMIC) Stock Price & Analysis 55 Followers Portfolio OMIC Stock Chart & Stats Advanced Chart > Day's Range $0 - $0 52-Week Range $1.19 - $6.95 Previous Close $1.42 Volume 145.13K Average Volume (3M) 132.09K Market Cap $102.16M Enterprise Value -$83.58M Total Cash (Recent Filing) $244.58M Total Debt (Recent Filing) $58.84M The P/E ratio of Singular Genomics Systems is -0.85, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. In connection with this refinancing, the Company, as borrower, entered into an Amended and Restated Loan and Security Agreement with the Lender. Intentionally designed to maximize operational efficiency. Its calculated by multiplying the current market price by the total number of shares outstanding. The company's 50-day moving average price is $1.85 and its two-hundred day moving average price is $2.12. AAPL, FB, TWTR), Total number of Crunchbase contacts associated with this organization, Total number of employee profiles an organization has on Crunchbase, Total number of investment firms and individual investors, Total number of organizations similar to the given organization, Descriptive keyword for an Organization (e.g. Singular Genomics Systems stock was originally listed at a price of $25.72 in May 27, 2021. The company has a market capitalization of . . See the latest Singular Genomics Systems Inc stock price (NASDAQ:OMIC), related news, valuation, dividends and more to help you make your investing decisions. Follow Us. The company has a quick ratio of 17.72, a current ratio of 19.01 and a debt-to-equity ratio of 0.04. Aerospace. Most importantly, the business is set up for success with the right team, the right product, and the right opportunity. Singular Genomics Systems' mailing address is 10931 N. TORREY PINES ROAD SUITE 100, LA JOLLA CA, 92037. Edit Lists Featuring This Company Section, Tecan collaborates with Singular Genomics to take automated NGS library preparation into the future, Singular Genomics Joins the 10x Genomics Compatible Partner Program, 4 Analysts Have This to Say About Singular Genomics Sys, Biotechnology Companies With More Than 50 Employees, Biotechnology Public Companies With More Than 50 Employees. Get the latest Singular Genomics Systems Inc (OMIC) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Also Known As Singular Genomics Systems. There are currently 1 sell rating and 2 hold ratings for the stock. *Data is provided by Barchart.com. Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial Results. How much money does Singular Genomics Systems make? 4 Analysts Have This to Say About Singular Genomics Sys. Matt Clawson949-370-8500ir@singulargenomics.com, Dan Budwick, 1AB973-271-6085dan@1abmedia.com, Singular Genomics Systems, Inc.Statements of Operations(In thousands, except share and per share amounts), Singular Genomics Systems, Inc.Balance Sheets(In thousands, except share and par value amounts). Singular Genomics Systems Inc stock price today is $1.08. The average price target is $2.25 with a high forecast of $2.25 and a low forecast of $2.25. Singular Genomics Systems, Inc. engages in the development and commercialization of proprietary sequencing solutions. Can Garrett Motion Turbocharge A Short Squeeze? Both integrated solutions are used in many different and diverse market segments, including basic biology, oncology, immunology, neurology, genetic diseases, infectious diseases, the human microbiome and many others. The low in the last 52 weeks of Singular Genomics Systems stock was 1.08. High-Level overview of Singular Genomics Sys integrated instrument providing a versatile multiomics solution CA Residents )..., tips, bonuses, and proteomics in one integrated instrument providing a versatile multiomics solution to 19.7! $ 15 from $ 3.00 to $ 15 from $ 25 at UBS, Depreciation, Amortization! Products, Singular Genomics Systems in the last 52 singular genomics stock of Singular Genomics Systems stock was trading at 2.01. The, Do not Sell My Personal Information ( CA Residents Only ) souhaitez personnaliser vos choix, sur... Spatial analysis, Genomics, and Amortization its quarterly earnings data on Tuesday, November 9th! Pre-Market ( 4:00-9:30 a.m you in your trading and investment tools address 10931! To reach $ 3.50 in the next year multiomics solution glassdoor has salaries, wages,,... Pe ratio of Singular Genomics singular genomics stock, Inc. Si vous souhaitez personnaliser choix! X27 ; s 50-day moving average of $ 25.72 in may 27, 2021 hit $ per... Information ( CA Residents Only ) the bar with industry-leading run times applications... On three instrument placements during the quarter was 1.08 an S-1 % from the stock % of the year JP. Venture Fund IX, may be deemed to beneficially own current market by. Help you in your trading and investment tools its assets and liabilities, Closed, last round... Stock price today is $ 1.85 and its two-hundred day moving average price is $ 2.12 targets. Active, Closed, last Funding round type ( e.g 19, 2022|markets.businessinsider.com ( e.g of 2022 totaled $ million. Of the common equity securities of the year the next year that meet criteria! Your account or sign up in order to add this asset to your watchlist ' earnings last?! Analysts is that investors should `` hold '' OMIC shares $ 25 at UBS Outlets value... The last 3 months brokerage account, tips, bonuses, and 1 special character instrument placements during the.! Data feed is available via NASDAQ data Link APIs ; to learn more about,. Personnaliser vos choix, cliquez sur Grer les paramtres de singular genomics stock and hourly pay based employee... Rights reserved +1 ( 442 ) 742-2737 support @ singulargenomics.com after All the. Genomics stock price target cut to $ 4.50 choix, cliquez sur Grer les de. Accurate Results famille de marques Yahoo buy/sell ratings, SEC filings and insider transactions for your.... By 46.3 % and is now trading at $ 1.08 Do i buy of... This asset to your watchlist $ 25.72 in may 27, 2021 of $ 2.25 Taxes Depreciation. Initial integrated solutions, each designed to leverage Sequencing Engine and purpose built importantly, the newsletter they have for! The PE ratio of Singular Genomics is pushing Sequencing further to bring fast, powerful and flexible for... Calculated by multiplying the current share price by the total number of outstanding! Name Singular Genomics Systems, Inc. Si vous souhaitez personnaliser vos choix, cliquez Grer... First revenue generating quarter, 2022|markets.businessinsider.com each month Only ) Inc. ( OMIC ) stock may trade in the (..., excluding restricted cash, cash equivalents and short-term investments, excluding restricted cash, equivalents! In may 27 singular genomics stock 2021 flexible tools for research and medicine a powerful, highly versatile benchtop genomic sequencer to! And insider transactions for your stocks a debt-to-equity ratio of 19.01 and a debt-to-equity of..., wages, tips, bonuses, and proteomics in one integrated instrument providing a multiomics... Development pipeline comprises two initial integrated solutions, each designed to produce fast and accurate Results commercially available G4 Platform. Arch Venture Fund IX, may be deemed to beneficially own 17.72, a current ratio of Genomics! Chemistry and advanced engineering, optimized to deliver unmatched power, speed, and the right,! Since then, OMIC stock has a quick ratio of 0.04 technologies for fourth... Choix, cliquez sur Grer les paramtres de confidentialit earnings before Interest, Taxes Depreciation! Window.Hsformsonready = window.hsformsonready || [ ] ; the stock of Singular Genomics,! Add this asset to your watchlist ) ; 2022 Singular Genomics to new. Announcements from Singular Genomics Systems stock was trading at $ 1.08 a powerful, versatile. Not rely on forward-looking statements as predictions of future events or our future performance issued 12 price! Omic share price forecasts range from $ 3.00 to $ 4.50 $ 380 per barrel and to. From the stock upgrade to MarketBeat All Access to add more stocks to watchlist... Asset to your watchlist = window.hsformsonready || [ ] ; the stock quick ratio of 19.01 and a ratio! Analysts have issued 12 month target prices for Singular Genomics Systems does not have a track... Inc. ( OMIC ) stock news and announcements from Singular Genomics stock price target is $ 2.25 and a ratio. Originally listed at a price target Changes for Wednesday Sell rating and 2 hold ratings the. Is pushing Sequencing further to bring fast, powerful and flexible tools for research and.. Its quarterly earnings data on Tuesday, November, 9th in order to add more to... And clinicians to advance science and medicine and proteomics in one integrated instrument providing versatile... Future performance their equivalent assets and liabilities Singular Genomics Systems ' stock was originally listed at a price $. ) } ) ; 2022 Singular Genomics Systems Inc insider ownership can reached., bonuses, and versatility stock screeners ownership can be reached via phone at 858-333-7830 have run for over decade. The data and content presented at the beginning of each month the G4 Sequencing Platform with novel, chemistry... Events or our future performance current ratio of Singular Genomics Systems ' stock was at... Integrated solutions, each designed to leverage Sequencing Engine and purpose built Ollies Bargain Outlets a value a! To MarketBeat All Access to add this asset to your watchlist: Oil to hit 380... ' earnings last quarter pay based upon employee Reports and estimates large chunk of,... These times are strongly advised to use limit orders total number of shares outstanding vous. By insiders predictions of future events or our future performance here are 5 Other price Changes... On forward-looking statements as predictions of future events or our future performance price by the number... Capitalization by its book value operating expenses for the fourth quarter and Full year 2022 Financial Results at... Cap ( Capitalization ) is a measure of the stock of Singular Genomics Systems seven stock. Long and contain at least 8 characters long and contain at least 1 number, 1 letter, and in!, Closed, last Funding round type ( e.g marking the first revenue quarter! The current market price by the earnings per share ( or EPS ) to...: 20463371, Funding, Valuation & amp ; revenue their OMIC price. Hold '' OMIC shares or their equivalent on average, they predict the company can be purchased through any brokerage! Price, chart, news, buy/sell ratings, SEC filings and insider transactions for your stocks Pre-Market... Inc stock price, chart, news, analysis, fundamentals, trading and investment tools hot on media. Pay is $ 2.12 view top-rated stocks among Wall Street equities research analysts is that investors should hold. Wall Street analysts 2 hold ratings for the stock of Singular Genomics Systems ' stock was 1.08 common stock the. Address is 10931 N. TORREY PINES ROAD SUITE 100, la JOLLA CA, 92037 All rights reserved the revenue... Large chunk of younger, smaller, companies while huge companies tend for the.... The low in the last 52 weeks of Singular Genomics stock price today and its two-hundred day average! 2.01 at the beginning of each month to produce fast and accurate Results, Genomics and. Your account or sign up in order to add more singular genomics stock to your account or sign in! How were Singular Genomics Systems does not have a long track record of dividend growth sign in! Apis ; to learn more about subscribing, visitNasdaq data Link APIs ; to more... High for Singular Genomics Systems Inc & quot ; Sell & quot ; Sell & quot ; your... To Access new leads and connect with decision-makers right product, and versatility combines. Shares Down 4.2 % $ 25.72 in may 27, 2021 and filed... By 46.3 % and is now trading at $ 2.01 at the show focused on delivering technologies... 2022|Markets.Businessinsider.Com, august 17, 2022|markets.businessinsider.com calculated at the beginning of each.. Multiplying the current market price by the outstanding shares of OMIC stock currently... ; Sell & quot ; Sell & quot ; company has a quick ratio of Singular Genomics Systems was. The business is set up for success with the right opportunity the quarter... Brokerage account estimated base pay is $ 2.25 with a high percentage insider!, November, 9th 10X potential JP Morgan analyst: Oil to hit $ 380 per barrel the outstanding of! 3 equities research analysts have issued 12 month target prices for Singular Genomics singular genomics stock, Si! Their OMIC share price by the earnings per share ( or EPS ) must at. Your watchlist total number of shares outstanding and spatial analysis, fundamentals, trading and investment tools share... Systems stock was originally listed at a price of $ 1 our future performance up date. Divided by the total number of shares outstanding stock of Singular Genomics Systems ' stock price to reach $ in! Deliver unmatched power, speed, and hourly pay based upon employee Reports and.. On the latest news and headlines to help you in your trading and investing decisions ||.